Gossamer Bio (STU:4GB) Other Long Term Assets : €0.25 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gossamer Bio Other Long Term Assets?

Gossamer Bio's other long-term assets for the quarter that ended in Sep. 2024 was €0.25 Mil.

Gossamer Bio's quarterly other long-term assets declined from Mar. 2024 (€0.56 Mil) to Jun. 2024 (€0.05 Mil) but then increased from Jun. 2024 (€0.05 Mil) to Sep. 2024 (€0.25 Mil).

Gossamer Bio's annual other long-term assets declined from Dec. 2021 (€0.96 Mil) to Dec. 2022 (€0.64 Mil) and declined from Dec. 2022 (€0.64 Mil) to Dec. 2023 (€0.57 Mil).

Gossamer Bio Other Long Term Assets Historical Data

The historical data trend for Gossamer Bio's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Other Long Term Assets Chart

Gossamer Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1.40

0.84

0.96

0.64

0.57

Gossamer Bio Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.61	0.57	0.56	0.05	0.25

Gossamer Bio Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Gossamer Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

GOSS:USA

Address

3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.gossamerbio.com

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines